Construct: ORF ccsbBroadEn_14728
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF018874.1_s300c1, BRDN0000458170
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- Early stop codon detected
Originally Annotated References:
- Gene:
- PAK3 (5063)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128166.2 | 98.2% | 44.6% | (many diffs) |
| 2 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128167.2 | 98.2% | 44.6% | (many diffs) |
| 3 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324325.2 | 98.2% | 44.6% | (many diffs) |
| 4 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324326.2 | 98.2% | 44.6% | (many diffs) |
| 5 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324330.2 | 98.2% | 44.6% | (many diffs) |
| 6 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324331.2 | 98.2% | 44.6% | (many diffs) |
| 7 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324332.2 | 98.2% | 44.6% | (many diffs) |
| 8 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324334.2 | 98.2% | 44.6% | (many diffs) |
| 9 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_002578.5 | 98.2% | 44.6% | (many diffs) |
| 10 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029561.2 | 98.2% | 44.6% | (many diffs) |
| 11 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128173.3 | 95.5% | 43.4% | (many diffs) |
| 12 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324327.2 | 95.5% | 43.4% | (many diffs) |
| 13 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324328.2 | 95.5% | 43.4% | (many diffs) |
| 14 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324329.2 | 95.5% | 43.4% | (many diffs) |
| 15 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001324333.2 | 95.5% | 43.4% | (many diffs) |
| 16 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029557.1 | 95.5% | 43.4% | (many diffs) |
| 17 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128172.2 | 94.5% | 43% | (many diffs) |
| 18 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_005262133.3 | 93.4% | 44.4% | (many diffs) |
| 19 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029558.1 | 93.4% | 44.4% | (many diffs) |
| 20 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029559.1 | 93.4% | 44.4% | (many diffs) |
| 21 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029560.1 | 93.4% | 44.4% | (many diffs) |
| 22 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NM_001128168.3 | 92.1% | 41.8% | (many diffs) |
| 23 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029563.1 | 92.1% | 41.8% | (many diffs) |
| 24 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_005262132.2 | 90.9% | 43.2% | (many diffs) |
| 25 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_006724654.2 | 90.9% | 43.2% | (many diffs) |
| 26 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_006724655.2 | 90.9% | 43.2% | (many diffs) |
| 27 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530962.1 | 90.9% | 43.2% | (many diffs) |
| 28 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530967.2 | 90.9% | 43.2% | (many diffs) |
| 29 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530968.2 | 90.9% | 43.2% | (many diffs) |
| 30 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530969.1 | 90.9% | 43.2% | (many diffs) |
| 31 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_017029562.1 | 90.4% | 45.5% | (many diffs) |
| 32 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | XM_011530971.2 | 54.3% | 72.1% | (many diffs) |
| 33 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NR_136748.1 | 18.1% | (many diffs) | |
| 34 | human | 5063 | PAK3 | p21 (RAC1) activated kinase 3 | NR_136747.2 | 17.5% | (many diffs) | |
| 35 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_001195049.1 | 90.8% | 43.1% | (many diffs) |
| 36 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_008778.3 | 90.8% | 43.1% | (many diffs) |
| 37 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_006528753.3 | 90.8% | 43.1% | (many diffs) |
| 38 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_006528754.3 | 90.8% | 43.1% | (many diffs) |
| 39 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_011247790.2 | 90.8% | 43.1% | (many diffs) |
| 40 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_001195048.1 | 88.3% | 42% | (many diffs) |
| 41 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_006528752.3 | 88.3% | 42% | (many diffs) |
| 42 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318423.1 | 88.3% | 42% | (many diffs) |
| 43 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_001195047.1 | 87.4% | 41.5% | (many diffs) |
| 44 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | NM_001195046.1 | 85.1% | 40.5% | (many diffs) |
| 45 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_006528747.3 | 85.1% | 40.5% | (many diffs) |
| 46 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318417.1 | 85.1% | 40.5% | (many diffs) |
| 47 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318418.1 | 85.1% | 40.5% | (many diffs) |
| 48 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318419.1 | 85.1% | 40.5% | (many diffs) |
| 49 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318420.1 | 85.1% | 40.5% | (many diffs) |
| 50 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318421.1 | 85.1% | 40.5% | (many diffs) |
| 51 | mouse | 18481 | Pak3 | p21 protein (Cdc42/Rac)-act... | XM_017318422.1 | 85.1% | 40.5% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 97
- ORF end:
- 838
- ORF length:
- 741
- Sequence:
-
1 ACGATTTTAT TTTGACTGAT AGTGACCTGT TCGTTGCAAC AAATTGATGA GCAATGCTTT 61 TTTATAATGC CAACTTTGTA CAAAAAAGTT GGCACCATGT CTGACGGTCT GGATAATGAA 121 GAGAAACCCC CGGCTCCTCC ACTGAGGATG AATAGTAACA ACCGGGATTC TTCAGCACTC 181 AACCACAGCT CCAAACCACT TCCCATGGCC CCTGAAGAGA AGAATAAGAA AGCCAGGCTT 241 CGCTCTATCT TCCCAGGAGG AGGGGATAAA ACCAATAAGA AGAAGGAGAA AGAGCGCCCA 301 GAGATCTCTC TTCCTTCAGA CTTTGAGCAT ACGATTCATG TGGGGTTTGA TGCAGTCACC 361 GGGGAATTCA CTGGAATTCC AGAGCAATGG GCACGATTAC TCCAAACTTC CAACATAACA 421 AAATTGGAAC AGAAGAAGAA CCCACAAGCT GTTCTAGATG TTCTCAAATT CTATGATTCC 481 AAAGAAACAG TCAACAACCA GAAATACATG AGCTTTACAT CAGGAGATAA AAGTGCACAT 541 GGATACATAG CAGCCCATCC TTCGAGTACA AAAACAGCAT CTGAGCCTCC ATTGGCCCCT 601 CCTGTGTCTG AAGAAGAAGA TGAAGAGGAA GAAGAAGAAG AAGATGAAAA TGAGCCACCA 661 CCAGTTATCG CACCAAGACC AGAGCATACA AAATCAATCT ATACTCGTTC TGTGGTTGAA 721 TCCATTGCTT CACCAGCAGT ACCAAATAAA GAGGTCACAC CACCCTCTGC TGAAAATGCC 781 AATTCCAGTA CTTTGTACAG GAACACAGAT CGGCAAAGAA AAAATCCAGA TGACAGATGA 841 GAGATCTTAG AGAGCTAGAG CATTGTGAGT GTGGGGACCC AAAGAAAAAA TAACACAGAT 901 TTGAAAAATT GGTcaaggGG CATCAGGTAC TGTTTATACA GCACTAGACA TTGCAACAGG 961 ACAGAAGGTG GCCATAAAGC AGATGACCCT CCAACAGCAA CCCCAAGAAG GANTNATTAT 1021 TATGNAAATC TGTNCATGAG GAAAAATAGA AACCNTAATA TTGTTAATAT TTAGATAGCT 1081 ACTTGGTGGG TGATGAACTA TGGGTAGTCA TGGAATACTT GGCTGGTGGC TCTCTGACTG 1141 ATGTGGTCAC AGAGACCTGT ATGGATGAAG GACAGATAGC AGCTGTCTGC AGAGAGTGCC 1201 TGCAAGCTTT GGATTTCCTG CACTCAAACC AGGTGATCCA TAGAGATATA AAGAGTGACA 1261 ATATTCTTCT CGGGATGGAT GGCTCTGTTA AATTGACTGA CTTTGGGTTC TGTGCCCAGA 1321 TCACTCCTGA GCAAAGTAAA CGAAGCACTA TGGTGGGAAC CCCATATTGG ATGGCACCTG 1381 AGGTGGTGAC TCGAAAAGCT TATGGTCCGA AAGTTGATAT CTGGTCTCTT GGAATTATGG 1441 CAATTGAAAT GGTGGAAGGT GAACCCCCTT ACCTTAATGA AAATCCACTC AGGGCATTGT 1501 ATCTGATAGC CACTAATGGA ACTCCAGAGC TCCAGAATCC TGAGAGACTG TCAGCTGTAT 1561 TCCGTGACTT TTTAAATCGC TGTCTTGAGA TGGATGTGGA TAGGCGAGGA TCTGCCAAGG 1621 AGCTTTTGCA GCATCCATTT TTAAAATTAG CCAAGCCTCT CTCCAGCCTG ACTCCTCTGA 1681 TTATCGCTGC AAAGGAAGCA ATTAAGAACA GCAGCCGCTT GCCAACTTTC TTGTACAAAG 1741 TTGGCATTAT AAGAAAGCAT TGCTTATCAA TTTGTTGCAA CGAACAGGTC ACTATCAGTC 1801 AAAATAAAAT CATTATTGCC ATCCCAGCCT GATAT